Related Experiment Video
Updated: Jul 10, 2026

Optical Sectioning and Visualization of the Intervertebral Disc from Embryonic Development to Degeneration
Published on: July 8, 2021
Intervertebral disc calcification in thalassemia intermedia
Athanassios Aessopos1, Maria Tsironi, Katerina Polonifi
1First Department of Internal Medicine, Medical School, Laiko Hospital, Athens, Greece.
Insights
Intervertebral disc calcification (IDC) affects 23.33% of beta-thalassemia intermedia patients over 30. Age and back pain history were linked to IDC, suggesting it may be overlooked in this population.
Area of Science:
- Hematology
- Radiology
- Orthopedics
Background:
- Intervertebral disc calcification (IDC) is an age-related condition.
- Beta-thalassemia involves excessive iron deposition and skeletal abnormalities.
- The prevalence of IDC in beta-thalassemia intermedia is not well-established.
Purpose of the Study:
- To determine the prevalence of Intervertebral Disc Calcification (IDC) in adult beta-thalassemia intermedia patients.
- To identify potential risk factors associated with IDC in this population.
Main Methods:
- Retrospective analysis of 30 beta-thalassemia intermedia patients aged over 30.
- Spinal X-rays (thoracic and lumbar) were used to detect IDC.
- Comparison of patients with and without IDC based on clinical and laboratory parameters.
Main Results:
- IDC was observed in 7 out of 30 patients (23.33%).
- Patients with IDC were significantly older and had a history of back pain.
- No significant differences were found in sex or laboratory parameters between groups.
Conclusions:
- IDC may be underestimated in beta-thalassemia patients due to co-existing spinal deformities.
- Further research is needed to understand the clinical significance and potential prevention of IDC in thalassemia.
- Early transfusion and chelation therapy might play a role in prevention.
Objectives:
Intervertebral disc calcification, an age-related phenomenon of variable clinical significance is described in hemochromatosis. As beta-thalassemia is characterized by excessive tissue iron deposition and secondary hemosiderosis, and skeletal abnormalities are often observed in these patients, this study is conducted to identify the prevalence of Intervertebral Disc Calcification (IDC) in thalassemia intermedia population.
Methods:
We investigated all the elder than 30 years beta-thalassemia intermedia patients of our Department thalassemia unit. Patients underwent thoracic and lumbar spinal X-rays for IDC presence. Patients presenting IDC were compared to those not presenting, regarding back pain anamnesis, presence of back pain, extramedullary hemopoiesis, sex, age, Hb levels, ferritin levels, reticulocytes, bilirubin values, thyroid-parathyroid abnormalities. Student's t-test was used to compare variables between patients with and without IDC. A P-value under 0.05 was considered statistically significant.
Results:
We investigated 30 beta-thalassemia intermedia patients (19 women) with an age range 38-61 yr (42.5 +/- 11.46 yr). Intervertebral disc calcifications were observed in seven patients (23.33%). No sex and laboratory parameters statistically significant differences were observed differences for IDC prevalence, while mean age and back pain history was statistically significantly different between the two groups.
Conclusions:
In thalassemia patients, the big variety of spinal deformities may hide the presence of IDC and thus, this entity may be overlooked or underestimated. The clinical significance of IDC development as well as the possible prevention by early transfusion chelation therapy should be further investigated.
Related Concept Videos
Degenerative Disc Disease I: Introduction
Herniated Intervertebral Disc l: Introduction
Degenerative Disc Disease ll: Pathophysiology
Structural Joints: Cartilaginous Joints
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary or...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
